Patents by Inventor Steven R. Deitcher

Steven R. Deitcher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CELLULAR COMPOSITIONS DERIVED FROM PRIOR ORGAN DONORS AND METHODS OF MANUFACTURE AND USE THEREOF
    Publication number: 20240115617
    Abstract: The invention provides compositions for establishing mixed chimerism in a subject. The compositions include CD34+ cells and CD3+ cells derived from an apheresis product obtained from a subject that has previously donated a solid organ. The invention also provides methods of making and using such compositions.
    Type: Application
    Filed: October 18, 2023
    Publication date: April 11, 2024
    Inventor: Steven R. Deitcher
  • Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
    Patent number: 11819521
    Abstract: The invention provides methods of making and using compositions for establishing mixed chimerism in a subject that include CD34+ cells and CD3+ cells derived from an apheresis product obtained from a subject that has previously donated a solid organ.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: November 21, 2023
    Assignee: MEDEOR THERAPEUTICS, INC.
    Inventor: Steven R. Deitcher
  • COMPOSITIONS FOR ESTABLISHING MIXED CHIMERISM AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20230302057
    Abstract: The invention provides compositions for establishing mixed chimerism in a subject. The compositions include CD34+ cells that have been column-purified from an apheresis product and CD3+ cells from an apheresis product that have not been purified through a column. The invention also provides methods of making and using such compositions.
    Type: Application
    Filed: June 1, 2023
    Publication date: September 28, 2023
    Inventor: Steven R. Deitcher
  • Compositions for establishing mixed chimerism and methods of manufacture thereof
    Patent number: 11701392
    Abstract: The invention provides compositions for establishing mixed chimerism in a subject. The compositions include CD34+ cells that have been column-purified from an apheresis product and CD3+ cells from an apheresis product that have not been purified through a column. The invention also provides methods of making and using such compositions.
    Type: Grant
    Filed: November 25, 2020
    Date of Patent: July 18, 2023
    Assignee: MEDEOR THERAPEUTICS, INC.
    Inventor: Steven R. Deitcher
  • METHODS FOR TREATING NON-CANCEROUS DISORDERS USING HEMATOPOIETIC CELLS
    Publication number: 20220152113
    Abstract: The invention provides methods of treating non-cancerous disorders in a subject by providing the subject with compositions containing hematopoietic cells. In certain embodiments, the compositions include CD34+ cells and CD3+ cells. In certain embodiments, the compositions include CD34+ cells and facilitating cells. The methods are useful for treating blood cell disorders and other disorders that can be ameliorated by providing donor hematopoietic cells.
    Type: Application
    Filed: February 3, 2022
    Publication date: May 19, 2022
    Inventors: Steven R. Deitcher, Corinna X. Chen
  • Methods for treating non-cancerous disorders using hematopoietic cells
    Patent number: 11273179
    Abstract: The invention provides methods of treating non-cancerous disorders in a subject by providing the subject with compositions containing hematopoietic cells. In certain embodiments, the compositions include CD34+ cells and CD3+ cells. In certain embodiments, the compositions include CD34+ cells and facilitating cells. The methods are useful for treating blood cell disorders and other disorders that can be ameliorated by providing donor hematopoietic cells.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: March 15, 2022
    Assignee: MEDEOR THERAPEUTICS, INC.
    Inventors: Steven R. Deitcher, Corinna X. Chen
  • COMPOSITIONS FOR ESTABLISHING MIXED CHIMERISM AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20210077534
    Abstract: The invention provides compositions for establishing mixed chimerism in a subject. The compositions include CD34+ cells that have been column-purified from an apheresis product and CD3+ cells from an apheresis product that have not been purified through a column. The invention also provides methods of making and using such compositions.
    Type: Application
    Filed: November 25, 2020
    Publication date: March 18, 2021
    Inventor: Steven R. Deitcher
  • CELLULAR COMPOSITIONS DERIVED FROM PRIOR ORGAN DONORS AND METHODS OF MANUFACTURE AND USE THEREOF
    Publication number: 20210030809
    Abstract: The invention provides methods of making and using compositions for establishing mixed chimerism in a subject that include CD34+ cells and CD3+ cells derived from an apheresis product obtained from a subject that has previously donated a solid organ.
    Type: Application
    Filed: October 16, 2020
    Publication date: February 4, 2021
    Inventor: Steven R. Deitcher
  • Compositions for establishing mixed chimerism and methods of manufacture thereof
    Patent number: 10881692
    Abstract: The invention provides compositions for establishing mixed chimerism in a subject. The compositions include CD34+ cells that have been column-purified from an apheresis product and CD3+ cells from an apheresis product that have not been purified through a column. The invention also provides methods of making and using such compositions.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: January 5, 2021
    Assignee: MEDEOR THERAPEUTICS, INC.
    Inventor: Steven R. Deitcher
  • Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
    Patent number: 10842821
    Abstract: The invention provides methods of making and using compositions for establishing mixed chimerism in a subject that include CD34+ cells and CD3+ cells derived from an apheresis product obtained from a subject that has previously donated a solid organ.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: November 24, 2020
    Assignee: MEDEOR THERAPEUTICS, INC.
    Inventor: Steven R. Deitcher
  • COMPOSITIONS FOR ESTABLISHING MIXED CHIMERISM AND METHODS OF MANUFACTURE THEREOF
    Publication number: 20190307803
    Abstract: The invention provides compositions for establishing mixed chimerism in a subject. The compositions include CD34+ cells that have been column-purified from an apheresis product and CD3+ cells from an apheresis product that have not been purified through a column. The invention also provides methods of making and using such compositions.
    Type: Application
    Filed: April 5, 2018
    Publication date: October 10, 2019
    Inventor: Steven R. Deitcher
  • CELLULAR COMPOSITIONS DERIVED FROM PRIOR ORGAN DONORS AND METHODS OF MANUFACTURE AND USE THEREOF
    Publication number: 20190307804
    Abstract: The invention provides compositions for establishing mixed chimerism in a subject. The compositions include CD34+ cells and CD3+ cells derived from an apheresis product obtained from a subject that has previously donated a solid organ. The invention also provides methods of making and using such compositions.
    Type: Application
    Filed: April 5, 2018
    Publication date: October 10, 2019
    Inventor: Steven R. Deitcher
  • METHODS FOR TREATING NON-CANCEROUS DISORDERS USING HEMATOPOIETIC CELLS
    Publication number: 20190275085
    Abstract: The invention provides methods of treating non-cancerous disorders in a subject by providing the subject with compositions containing hematopoietic cells. In certain embodiments, the compositions include CD34+ cells and CD3+ cells. In certain embodiments, the compositions include CD34+ cells and facilitating cells. The methods are useful for treating blood cell disorders and other disorders that can be ameliorated by providing donor hematopoietic cells.
    Type: Application
    Filed: March 12, 2019
    Publication date: September 12, 2019
    Inventors: Steven R. Deitcher, Corinna X. Chen